Your session is about to expire
← Back to Search
Procedure
MR-Guided Focused Ultrasound for Depression
N/A
Waitlist Available
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial is testing whether a new brain surgery called MRgFUS is safe and effective for people with treatment-refractory Major Depression.
Eligible Conditions
- Depression
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of Treatment-Emergent Adverse Events
Secondary outcome measures
Clinical efficacy will be measured using the Beck Depression Inventory (BDI)
Clinical efficacy will be measured using the Columbia-Suicide Severity Rating Scale (C-SSRS)
Clinical efficacy will be measured using the Hamilton Rating Scale for Depression (HAMD)
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: MR-Guided Focused UltrasoundExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MR-guided Focused Ultrasound
2018
N/A
~20
Find a Location
Who is running the clinical trial?
Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,551,424 Total Patients Enrolled
36 Trials studying Depression
9,526 Patients Enrolled for Depression
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger